These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 20868890)

  • 21. [Screening for breast cancer on basis of individual risk assessment for women ineligible for the national population screening program].
    van Asperen CJ; de Bock GH; van der Horst F; de Koning HJ; Rutgers EJ
    Ned Tijdschr Geneeskd; 2001 Jan; 145(3):120-5. PubMed ID: 11206121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasound.
    Pediconi F; Catalano C; Roselli A; Dominelli V; Cagioli S; Karatasiou A; Pronio A; Kirchin MA; Passariello R
    Invest Radiol; 2009 Jul; 44(7):412-21. PubMed ID: 19448554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.
    Lehman CD; Blume JD; Weatherall P; Thickman D; Hylton N; Warner E; Pisano E; Schnitt SJ; Gatsonis C; Schnall M; DeAngelis GA; Stomper P; Rosen EL; O'Loughlin M; Harms S; Bluemke DA;
    Cancer; 2005 May; 103(9):1898-905. PubMed ID: 15800894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recommendations for the surveillance of young women at increased risk for breast cancer.
    Hadden WE
    Australas Radiol; 2007 Feb; 51(1):1-11. PubMed ID: 17217483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of magnetic resonance imaging in screening women at high risk of breast cancer.
    Warner E
    Top Magn Reson Imaging; 2008 Jun; 19(3):163-9. PubMed ID: 18941396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Issues in breast imaging.
    Cole CF
    Lippincotts Prim Care Pract; 1998; 2(2):141-8. PubMed ID: 9727110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-risk screening: multi-modality surveillance of women at high risk for breast cancer (proven or suspected carriers of a breast cancer susceptibility gene).
    Kuhl CK
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):103-6. PubMed ID: 12585663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of costs and benefits of breast cancer screening with mammography, ultrasonography, and MRI.
    Feig S
    Obstet Gynecol Clin North Am; 2011 Mar; 38(1):179-96, ix. PubMed ID: 21419333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. When is breast magnetic resonance imaging recommended for cancer detection?
    Miller JC; Rafferty EA; Specht MC; Thrall JH; Lee SI
    J Am Coll Radiol; 2008 Mar; 5(3):224-6. PubMed ID: 18312973
    [No Abstract]   [Full Text] [Related]  

  • 30. Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer.
    Riedl CC; Ponhold L; Flöry D; Weber M; Kroiss R; Wagner T; Fuchsjäger M; Helbich TH
    Clin Cancer Res; 2007 Oct; 13(20):6144-52. PubMed ID: 17947480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast magnetic resonance imaging for screening high-risk women.
    Sung JS; Dershaw DD
    Magn Reson Imaging Clin N Am; 2013 Aug; 21(3):509-17. PubMed ID: 23928241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer screening update.
    Tria Tirona M
    Am Fam Physician; 2013 Feb; 87(4):274-8. PubMed ID: 23418799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening and diagnosis of breast cancer in augmented women.
    Uematsu T
    Breast Cancer; 2008; 15(2):159-64. PubMed ID: 18293060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast MR imaging screening in eight women proved or suspected to be carriers of BRCA1&2 gene mutations.
    Cilotti A; Caligo MA; Cipollini G; Francesca D; Marini C; Moretti M; Roncella M; Bartolozzi C; Bevilacqua G
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):137-40. PubMed ID: 12585668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contemporary management of breast cancer.
    Marchant DJ
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):555-60. PubMed ID: 7731634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The "EVA" Trial: Evaluation of the Efficacy of Diagnostic Methods (Mammography, Ultrasound, MRI) in the secondary and tertiary prevention of familial breast cancer. Preliminary results after the first half of the study period].
    Kuhl CK; Schrading S; Weigel S; Nüssle-Kügele K; Sittek H; Arand B; Morakkabati N; Leutner C; Tombach B; Nordhoff D; Perlet C; Rieber A; Heindel W; Brambs HJ; Schild H
    Rofo; 2005 Jun; 177(6):818-27. PubMed ID: 15902631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of MRI in screening women at high risk for breast cancer.
    Lehman CD
    J Magn Reson Imaging; 2006 Nov; 24(5):964-70. PubMed ID: 17036340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An imaging approach to high-risk screening for breast cancer.
    Jochelson MS; Morris EA
    Semin Roentgenol; 2011 Jan; 46(1):68-75. PubMed ID: 21134530
    [No Abstract]   [Full Text] [Related]  

  • 39. Breast cancer screening and problem solving using mammography, ultrasound, and magnetic resonance imaging.
    Hooley RJ; Andrejeva L; Scoutt LM
    Ultrasound Q; 2011 Mar; 27(1):23-47. PubMed ID: 21343800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 2009 US Preventive Services Task Force (USPSTF) guidelines are not supported by science: the scientific support for mammography screening.
    Kopans DB
    Radiol Clin North Am; 2010 Sep; 48(5):843-57. PubMed ID: 20868889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.